ATE31931T1 - Peptide und ihre verwendung in der therapie. - Google Patents
Peptide und ihre verwendung in der therapie.Info
- Publication number
- ATE31931T1 ATE31931T1 AT84306950T AT84306950T ATE31931T1 AT E31931 T1 ATE31931 T1 AT E31931T1 AT 84306950 T AT84306950 T AT 84306950T AT 84306950 T AT84306950 T AT 84306950T AT E31931 T1 ATE31931 T1 AT E31931T1
- Authority
- AT
- Austria
- Prior art keywords
- phe
- cys
- peptides
- therapy
- thr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/16—Somatostatin; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/540,380 US4485101A (en) | 1983-10-11 | 1983-10-11 | Peptides |
| EP84306950A EP0142272B1 (de) | 1983-10-11 | 1984-10-11 | Peptide und ihre Verwendung in der Therapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE31931T1 true ATE31931T1 (de) | 1988-01-15 |
Family
ID=24155205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84306950T ATE31931T1 (de) | 1983-10-11 | 1984-10-11 | Peptide und ihre verwendung in der therapie. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4485101A (de) |
| EP (1) | EP0142272B1 (de) |
| JP (1) | JPH0635479B2 (de) |
| AT (1) | ATE31931T1 (de) |
| CA (1) | CA1265899A (de) |
| DE (1) | DE3468688D1 (de) |
| ZA (1) | ZA847960B (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
| US4863899A (en) * | 1983-05-09 | 1989-09-05 | Todaro George J | Biologically active polypeptides |
| JPS6034997A (ja) * | 1983-05-09 | 1985-02-22 | ジヨージ、ジヨセフ、トダロ | 生物学的活性ポリペプチド類 |
| US4904642A (en) * | 1985-09-12 | 1990-02-27 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
| US4853371A (en) * | 1986-06-17 | 1989-08-01 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
| GB8620035D0 (en) * | 1986-08-18 | 1986-10-01 | Sandoz Ltd | Organic compounds |
| US4871717A (en) * | 1987-01-07 | 1989-10-03 | Administrators Of The Tulane Educational Fund | Peptides |
| GB2239178B (en) * | 1987-07-10 | 1991-11-27 | Sandoz Ltd | Somatostatin analogues for the treatment of breast cancer |
| US5073541A (en) * | 1987-11-18 | 1991-12-17 | Administrators Of The Tulane Educational Fund | Treatment of small cell lung cancer with somatostatin analogs |
| GB8813160D0 (en) * | 1988-06-03 | 1988-07-06 | Soc D Etudes Prod Chimique | Therapeutic methods |
| US5633263A (en) * | 1989-04-26 | 1997-05-27 | The Administrators Of The Tulane Educational Fund | Linear somatostatin analogs |
| HU221294B1 (en) * | 1989-07-07 | 2002-09-28 | Novartis Ag | Process for producing retarde compositions containing the active ingredient in a polymeric carrier |
| US5443816A (en) * | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
| US5460785A (en) * | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
| ES2091907T3 (es) * | 1989-12-08 | 1996-11-16 | Univ Tulane | Analogos octapeptidos de somatostina con una threonina en la sexta posicion. |
| ATE181240T1 (de) * | 1991-02-08 | 1999-07-15 | Biomeasure Inc | Verwendung von somatostatinanalogen zur behandlung von melanomen |
| US5225180A (en) * | 1991-09-10 | 1993-07-06 | Diatech, Inc. | Technetium-99m labeled somatostatin-derived peptides for imaging |
| US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
| US5643549A (en) * | 1992-02-20 | 1997-07-01 | Rhomed Incorporated | Leukostimulatory agent for in vivo leukocyte tagging |
| US5620675A (en) | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
| US5871711A (en) * | 1992-06-23 | 1999-02-16 | Diatide, Inc. | Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
| US6017512A (en) * | 1992-06-23 | 2000-01-25 | Diatide, Inc. | Radiolabeled peptides |
| US5504069A (en) * | 1993-02-11 | 1996-04-02 | Biomeasure, Inc. | Inhibition of trauma-induced tumor growth |
| US5932189A (en) * | 1994-07-29 | 1999-08-03 | Diatech, Inc. | Cyclic peptide somatostatin analogs |
| US6051206A (en) * | 1994-06-03 | 2000-04-18 | Diatide, Inc | Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| US5597894A (en) * | 1995-06-05 | 1997-01-28 | The Louisiana State University Medical Center Foundation | Multi-tyrosinated somatostatin analogs |
| EP0981364B1 (de) * | 1997-05-13 | 2006-03-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Methoden und zusammensetzungen zur behandlung der hyperlipidämie |
| US6004928A (en) * | 1997-05-13 | 1999-12-21 | Biomeasure, Incorporated | Method of treating hyperlipidemia |
| CA2290592A1 (en) * | 1997-05-13 | 1998-11-19 | Michael Anthony Cawthorne | Somatostatin and somatostatin agonists for decreasing body weight |
| CA2289499C (en) * | 1997-05-13 | 2010-02-23 | Michael Anthony Cawthorne | Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x |
| US5968903A (en) * | 1998-05-07 | 1999-10-19 | Biomeasure, Incorporated | Inhibition of H. pylori proliferation |
| CA2246791A1 (en) * | 1998-09-01 | 2000-03-01 | Alison Buchan | Treatment of endothelium with somatostatin analogues |
| JP2002089791A (ja) * | 2000-09-14 | 2002-03-27 | Sumitomo Precision Prod Co Ltd | 液化ガス気化装置 |
| JP2002340296A (ja) * | 2001-05-16 | 2002-11-27 | Sumitomo Precision Prod Co Ltd | 液化ガス気化・加熱装置 |
| NZ530007A (en) | 2001-06-08 | 2006-02-24 | Sod Conseils Rech Applic | Somatostatin-dopamine chimeric analogues that retain both somatostatin and dopamine activity in vivo and display enhanced biological activity |
| ES2372685T3 (es) * | 2002-03-29 | 2012-01-25 | Excelerate Energy Limited Partnership | Procedimiento y equipo para la regasificación de gnl a bordo de un carguero. |
| JP2006522100A (ja) * | 2003-03-10 | 2006-09-28 | バイオジェン アイデック インク | 標的化ペプチドに対するチオール媒介性薬物結合 |
| CA2523197C (en) | 2003-04-22 | 2016-05-24 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Peptide vectors |
| FI20031454A0 (fi) | 2003-10-06 | 2003-10-06 | Juvantia Pharma Ltd Oy | Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja |
| WO2006123020A1 (en) * | 2005-05-18 | 2006-11-23 | Juvantia Pharma Ltd Oy | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| SG185008A1 (en) | 2010-05-20 | 2012-11-29 | Excelerate Energy Ltd Partnership | Systems and methods for treatment of lng cargo tanks |
| EP3007704B1 (de) | 2013-06-13 | 2021-01-06 | Antisense Therapeutics Ltd | Kombinationstherapie der akromegalie |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| JP7099717B2 (ja) | 2019-09-30 | 2022-07-12 | 株式会社理研バイオ | ソマトスタチン受容体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2416048A1 (de) * | 1974-04-03 | 1975-10-30 | Hoechst Ag | Neue peptide mit biologischer wirkung |
| DE2519656A1 (de) * | 1974-05-13 | 1975-11-27 | Sandoz Ag | Neue peptide und verfahren zu ihrer herstellung |
| DE2608336A1 (de) * | 1975-03-11 | 1976-09-30 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
| US4372884A (en) * | 1975-08-06 | 1983-02-08 | The Salk Institute For Biological Studies | Pharmaceutically active peptides |
| US4133782A (en) * | 1976-06-07 | 1979-01-09 | The Salk Institute For Biological Studies | Somatostatin analogs with dissociated biological activities |
| US4190575A (en) * | 1977-12-27 | 1980-02-26 | American Home Products Corporation | Polypeptides related to somatostatin |
| GB1578402A (en) * | 1977-02-22 | 1980-11-05 | American Home Prod | Somatostatin peptide analogues |
| US4211693A (en) * | 1977-09-20 | 1980-07-08 | The Salk Institute For Biological Studies | Peptides with para-substituted phenylalanine |
| CA1107273A (en) * | 1978-05-19 | 1981-08-18 | Chester A. Meyers | Somatostatin analogs having a substituted tryptophyl residue in position eight |
| US4215039A (en) * | 1979-02-15 | 1980-07-29 | American Home Products Corporation | Somatostatin analogues |
| US4209426A (en) * | 1979-05-29 | 1980-06-24 | American Home Products Corporation | Polypeptides related to somatostatin |
| US4369179A (en) * | 1979-12-14 | 1983-01-18 | Ciba-Geigy Corporation | Acylpeptides |
-
1983
- 1983-10-11 US US06/540,380 patent/US4485101A/en not_active Expired - Lifetime
-
1984
- 1984-10-10 CA CA000465005A patent/CA1265899A/en not_active Expired - Lifetime
- 1984-10-11 JP JP59213257A patent/JPH0635479B2/ja not_active Expired - Lifetime
- 1984-10-11 DE DE8484306950T patent/DE3468688D1/de not_active Expired
- 1984-10-11 ZA ZA847960A patent/ZA847960B/xx unknown
- 1984-10-11 EP EP84306950A patent/EP0142272B1/de not_active Expired
- 1984-10-11 AT AT84306950T patent/ATE31931T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA847960B (en) | 1985-06-26 |
| DE3468688D1 (en) | 1988-02-18 |
| US4485101A (en) | 1984-11-27 |
| EP0142272B1 (de) | 1988-01-13 |
| JPS60149599A (ja) | 1985-08-07 |
| CA1265899A (en) | 1990-02-13 |
| JPH0635479B2 (ja) | 1994-05-11 |
| EP0142272A1 (de) | 1985-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3468688D1 (en) | Peptides and their use in therapy | |
| DK151985D0 (da) | Humant fysiologisk aktivt polypeptid | |
| DE3689246D1 (de) | Physiologisch aktives Polypeptid BUF-3. | |
| NO843592L (no) | Fremgangsmaate for fremstilling av et polypeptid | |
| DK496486A (da) | Polypeptid | |
| DK193887A (da) | Peptid med bronchodilartorisk og hypotensiv aktivitet | |
| FI900899A0 (fi) | Menetelmä naulalevykattotuolin valmistamiseksi | |
| DK162890D0 (da) | Polypeptid | |
| FI894007A7 (fi) | Neuropeptidi Y:n antagonisteja | |
| DK551287A (da) | Polypeptid | |
| ES539068A0 (es) | Un derivado de polipeptido de interferon-a humano | |
| DK383985D0 (da) | Polypeptid | |
| EP0333071A3 (de) | Polypeptide, deren Methoden zur Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und Verwendung | |
| DK354389D0 (da) | Polypeptid | |
| DE69232716D1 (de) | Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung | |
| DK50987A (da) | Polypeptid med plasminogenaktivatorvirkning | |
| ITRM910115A0 (it) | Nuovo impiego terapeutico dei peptidi della somatostatina | |
| FI901369A7 (fi) | Bombesiinireseptorien irreversiibelit peptidiligandit | |
| DK110585D0 (da) | Insulinforstaerkende peptider | |
| DK88790D0 (da) | Terapeutisk virksomme midler | |
| FI890175A7 (fi) | Ihmisen yhdistelmä-interleukiini-1-a-polypeptidejä | |
| NO832148L (no) | Fremgangsmaate for fremstilling av et farmakologisk aktivt polypeptid | |
| IT8921992A0 (it) | N,n'-di-(trimetossibenzoil) piperazine 2-carbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono | |
| DE69119896D1 (de) | Neue verwendung von bambuterol | |
| DE3752082D1 (de) | Therapeutische Somatostatin-Analoge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |